Search Within

Elisa De Stanchina

Formats
  1. Journal Article (244)
  2. Meeting Abstract (104)
  3. Book Section (4)
  4. Research Letter (3)
  5. Book Whole (1)
  6. Correspondence (1)
  7. Review (1)
Groups
  1. GSK Faculty (288)
  2. Sloan Kettering Institute Postdocs (257)
  3. Department of Medicine (251)
  4. Solid Tumor Oncology Division (206)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (160)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (154)

More Groups

People
  1. Charles Rudin (70)
  2. Marissa Mattar (44)
  3. Marc Ladanyi (43)
  4. Neal Rosen (37)
  5. Inna Khodos (35)
  6. Romel Somwar (33)

More People

Years
  1. 2025 (22)
  2. 2024 (30)
  3. 2023 (23)
  4. 2022 (51)
  5. 2021 (43)
  6. 2020 (28)

More Years

Publications
  1. Cancer Research (52)
  2. Cancer Discovery (25)
  3. Clinical Cancer Research (19)
  4. Blood (16)
  5. Journal of Thoracic Oncology (16)
  6. Journal of Clinical Oncology (15)

More Publications

Publishers
  1. American Association for Cancer Research (112)
  2. Nature Publishing Group (45)
  3. Cell Press (37)
  4. Elsevier Inc. (27)
  5. American Society of Clinical Oncology (18)
  6. American Society of Hematology (16)

More Publishers

Results (358)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Exportin 1 inhibition as a therapeutic strategy for small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Multiomic profiling of patient-derived xenografts established from patients with malignant pleural mesothelioma proposes pathways associated with poor prognosis
    Meeting Abstract

    Offin, M.; Sauter, J. L.; Egger, J. V.; deStanchina, E.; Poirier, J. T.; Zauderer, M. G.; Rudin, C.; Sen, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversibility of tumor adaptations to PI3K inhibition decreases as a function of time
    Meeting Abstract

    Mukherjee, R.; de Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologically induced polyploidy triggers BCL2 dependence in lymphomas
    Meeting Abstract

    Portelinha, A.; da Silva Ferreira, M.; Erazo, T.; Asgari, Z.; de Stanchina, E.; Younes, A.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; Egger, J.; Qiu, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
    Meeting Abstract

    Tang, F.; Xu, D.; Wang, S.; Wong, C. K.; Martinez-Fundichely, A.; Lee, C.; Cohen, S.; Park, J.; Hill, C.; Eng, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype and promotes immune surveillance in PDAC
    Meeting Abstract

    Chibaya, L.; Murphy, K. C.; Diaz, Y. L.; DeMarco, K. D.; Liu, H.; Gopalan, S.; Faulkner, M.; Li, J.; Morris, J. P. 4th; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; RivieĢ€re, I.; more...
    Blood (2022)

    Fulltext@MSK | Save